Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: FASEB J. 2023 Nov;37(11):e23248. doi: 10.1096/fj.202301185R

TABLE 4:

The most relevant pathways involved in fatostatin-treated HTM cells using lipidomic pathway analysis

Pathways Total Compound Hits Raw p FDR Impact
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis 14 1 0.17694 0.65345 0.00399
Glycerophospholipid metabolism 36 4 0.40972 0.65345 0.26332
Arachidonic acid metabolism 36 1 0.46277 0.65345 0
Linoleic acid metabolism 5 1 0.46277 0.65345 0
alpha-Linolenic acid metabolism 13 1 0.46277 0.65345 0
Biosynthesis of unsaturated fatty acids 36 1 0.49008 0.65345 0
Sphingolipid metabolism 21 2 0.83211 0.88546 0.26978
Steroid biosynthesis 42 1 0.88546 0.88546 0

The table shows the detailed results for pathways relevant to fatostatin treatment. Columns (left to right) denote the pathway names, the total number of compounds in the pathway (Total Compound), the matched number from the lipidomics data (Hits), the original p value calculated from the enrichment analysis (Raw p), the p-value adjusted using False Discovery Rate (FDR), and the pathway impact value calculated from pathway topology analysis (Impact).